Skip to content
Recall Observatory FDA recall evidence

Drug product

BUPRENORPHINE HYDROCHLORIDE Sublingual Tablets, 8 mg, 30-count bottles, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-5379-56, UPC 3 0093-5379-56 2.

D-1325-2014

April 07, 2014

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 68069
Status
Terminated
Classification
Class II
Quantity
53,452 bottles
Official record key
drug-enforcement:D-1325-2014

Official wording

Reason: Failed Impurities/Degradation Specifications: High out of specification impurity test results were obtained during stability testing.

Code information: 34009367B, 34009368B, 34009369A, 34009370B, Exp 04/14; 34013141A, 34013142A, Exp 11/14; 34016682A, 34016683A, 34016684A, 34017000A, 34017001A, Exp 08/15

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification